Home > Products > Novel inhibitors
Cat. No. Product name CAS No.
DCC1588 Ctr-21

Novel anticancer agent, effectively killing multi-drug resistant cancer cells and a panel of different cancer cells originated from a variety of different tissues including breast and skin, preventing tubulin polymerization, leading to the cell cycle arre

2098310-96-2
DCC1589 Ctr-32

Novel anticancer agent, effectively killing multi-drug resistant cancer cells and a panel of different cancer cells originated from a variety of different tissues including breast and skin, preventing tubulin polymerization, leading to the cell cycle arre

DCC1590 Ctt-54.2 Potassium

Inhibitor of prostate-specific membrane antigen (PSMA)

1291095-95-8
DCC1591 Ctw0415

Novel Serotonin 5-HT 2C Receptor Positive Allosteric Modulator (PAM) with Enhanced Drug-like Properties

DCC1592 Cu-6pmn

Novel fluorescent RXR agonist

DCC1593 Cugamycin

Novel r(CUG) repeat expansion cleaver, specifically recognizing the 3-dimensional structure of r(CUG)exp, cleaving it more selectively among transcripts containing short, nonpathogenic r(CUG) repeats than an oligonucleotide that recognizes RNA sequence vi

DCC1594 Cumi-101

5-HT1A receptor agonist

179756-61-7
DCC1595 Cumyl-pica

Agonist for the cannabinoid receptors, with Ki values of 59.21 nM at CB1 and 136.38 nM at CB2 and EC50 values of 11.98 nM at CB1 and 16.2 nM at CB2

1400742-32-6
DCC1596 Cuprizone

Inducer of demyelination and motor dysfunction via upregulation of IGF-1

370-81-0
DCC1597 Cv21/jr95

Potent anti-cancer agent

1353182-67-8
DCC1598 Cvk-003

Novel dual PXR and AhR agonist

DCC1599 Cvk-021

Novel potent pregnane X Receptor (PXR) agonist

DCC1600 Cvm-04-70

Inhibitor of PIM, suppressing cyclin-Dependent Kinase 2 (CDK2)

DCC1601 Cvm-05-002

Novel potent and selective inhibitor of PI5P4Ks

DCC1602 Cvs-1123

Direct thrombin inhibitor, preventing occlusive arterial and venous thrombosis in a canine model of vascular injury

151275-19-3
DCC1603 Cvs-1578

Potent serine protease inhibitor, targeting the S 2 S 3 thrombin and FXa subsites

186318-81-0
DCC1604 Cwhm-1552

Novel orally efficacious antimalarial agent against P. falciparum 3D7 ( IC50: 51 nM)

2368253-58-9
DCC1605 Cwhm-505

Potent antimalarial agent against Plasmodium falciparum 3D7

1695611-59-6
DCC1606 Cwhm-505 Hydrochloride

Potent antimalarial agent against Plasmodium falciparum 3D7

1695560-60-1
DCC1607 Cwp231904

Novel Wnt/β-Catenin Inhibitor, Preferentially Inhibiting the Growth of Breast Cancer Stem-like Cells

DCC1608 Cx08005

Novel potent and substrate-competitive PTP1B and TCPTP dual inhibitor

1256341-22-6
DCC1609 Moxilubant Maleate

Potent LTB4 receptor antagonist

147398-01-4
Page 1294 / Total 1557 FirstPrevNextLastGoto